Sweden· SE-19990209000018
Relenza 5 mg/dos Inhalationspulver, avdelad dos
A medicinal product containing zanamivir, registered in Sweden by GlaxoSmithKline AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Zanamivir
- Manufacturer
- GlaxoSmithKline AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19990209000018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zanamivir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDectova 200mg/20ml solution for infusion vialsGlaxoSmithKline UK Ltd
- United StatesRELENZAGlaxoSmithKline LLC
- BelgiumDectova 10 mg/mlGlaxoSmithKline Pharmaceuticals
- SpainDECTOVA 10 MG/ML SOLUCION PARA PERFUSIONGlaxosmithkline Trading Services Limited
- FinlandDectovaGlaxoSmithKline Trading Services Limited
- IrelandDectova 10 mg/mL solution for infusionGlaxoSmithKline Trading Services Limited
- IcelandDectovaGlaxoSmithKline Trading Services Limited
- NetherlandsDectova 10 mg/ml, oplossing voor infusieGlaxoSmithKline Trading Services Limited
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Relenza Rotadisks
- Belgium · Relenza
- Bulgaria · Реленца
- Germany · Relenza
- Denmark · Relenza
- Spain · Relenza
- Finland · Relenza
- France · Relenza
- United Kingdom (Northern Ireland) · Relenza
- Croatia · Relenza
- Ireland · Relenza
- Iceland · Dectova, Relenza
- Italy · Relenza
- Liechtenstein · Dectova
- Luxembourg · Relenza
- Netherlands · Relenza
- Norway · Dectova, Relenza
- Poland · Relenza
- Portugal · Relenza
- Slovenia · Relenza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5e1a9cb-dfe4-455b-a36c-d8fb5944641f GET /v1/drugs/f5e1a9cb-dfe4-455b-a36c-d8fb5944641f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "19990209000018",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19990209000018",
"product_doc_link": "https://docetp.mpa.se/LMF/Relenza%20inhalation%20powder%2C%20pre-dispensed%20SmPC_09001bee807a6e16.pdf"
}See everything about zanamivir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.